StockData
Curaleaf Holdings, Inc. logo

Curaleaf Holdings, Inc. (CURLF) stock

CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30
$7.63−0.20 (-2.55%)

Close on Oct 19, 2026Market cap $2.07BP/E –Yield –

Curaleaf revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $1.27B, down 5.0% from the year before. The highest annual figure on record is $1.35B in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.27B-5.0%
FY2024Dec 31, 2024$1.33B-0.9%
FY2023Dec 31, 2023$1.35B+5.6%
FY2022Dec 31, 2022$1.28B+6.6%
FY2021Dec 31, 2021$1.20B+90.9%
FY2020Dec 31, 2020$626.64M+183.5%
FY2019Dec 31, 2019$221.02M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$340.10M–
Q2 FY2025Jun 30, 2025$310.59M–

More Curaleaf figures

See a number that looks wrong?